FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Regnum Corp. Stock AnalysisComprehensive stock analysis for Regnum Corp. (RGMP) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRGMP
RGMP
Regnum Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RGMP
Home🔹Stocks🔹Regnum Corp.

Regnum Corp.

🇺🇸RGMP•OTC

Regnum Corp.

🇺🇸RGMP•OTC
Market cap
$2.29K
Sentiment

Your view on RGMP

Mkt Cap
$2.29K
Sentiment
Your view
RGMP
Regnum Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RGMP
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Regnum Corp.

Industry
Entertainment
Sector
Communication Services
CEO
Robert J. Stubblefield
Headquarters
600 Third Avenue, New York City, NY, US
Industry
Entertainment
Sector
Communication Services
CEO
Robert J. Stubblefield
Headquarters
600 Third Avenue, New York City, NY, US
Description

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells.

The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Regnum Corp., and the rating behind it. RGMP last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Regnum Corp.. Starting points for Regnum Corp.: EPS -$0.03, beta -0.47 — an Entertainment name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Regnum Corp.. Regnum Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Regnum Corp.. Trailing twelve-month EPS for Regnum Corp. stands at -$0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Regnum Corp.. Regnum Corp. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Regnum Corp. valued side by side against its closest peers. Regnum Corp. is measured against Entertainment peers within the Communication Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Regnum Corp., and how their positions are changing. At a $2,295 market value, institutional positions materially move Regnum Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Regnum Corp. executives and directors. Shares of Regnum Corp. have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Regnum Corp.. Regnum Corp. is a $2,295 Communication Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Regnum Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Regnum Corp.. Coverage tracks Regnum Corp. within Entertainment (Communication Services). Press releases and market coverage, newest first.

Peer companies

  • AMPE — Ampio Pharmaceuticals, Inc.
  • BIOAF — Bioasis Technologies Inc.
  • DVLP — Golden Developing Solutions, Inc.
  • EVARF — Lombard Medical, Inc.
  • GBLX — GB Sciences, Inc.
  • GSTC — GlobeStar Therapeutics Corporation
  • NEPTF — Neptune Wellness Solutions Inc.

More Entertainment companies

  • STRZ — Starz Entertainment Corp.
  • STV.AX — Swift TV Ltd
  • SVSN — Stereo Vision Entertainment, Inc.
  • SWMD — Starwin Media Holdings Inc.
  • TCHC — Tech Central, Inc.
  • TGE — Generation Essentials Group
  • TIXC — Tix Corporation
  • TKCOF — Toho Co., Ltd.
  • TKO — TKO Group Holdings, Inc.
  • TOEAF — Toei Animation Co.,Ltd.
  • TOON — Kartoon Studios Inc.
  • UMGNF — Universal Music Group N.V.

News

Latest Market News